Sun Pharma in focus: Drug major Sun Pharmaceutical has received approval from the US health regulator for its new drug application for acne treatment medicine--XiminoTM extended-release capsules.
The market on Thursday plunged sharply in the last final hours of trade. The Sensex slipped 323.82 points or 1 percent at 27607.82 and the Nifty lost 122.40 points or 1 percent at 8372.75.
About 787 shares have advanced, 2053 shares declined, and 105 shares are unchanged. Rupee was at fresh two-year low, at 65.48 per dollar now. Brent Crude too was struggling.
Pharma and FMCG stocks outperformed with big gainers like Lupin, ITC, Dr Reddy's Labs, Sun Pharma and HUL. Banks, metals, IT and auto stocks were hammered out of shape. Vedanta, Reliance, BHEL, Tata Steel and Axis Bank were major laggards in the Sensex
Comments
0 comment